StockData
Profusa, Inc. logo

Profusa, Inc. (PFSA) stock

PFSANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NVACW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.35+0.01 (+1.84%)

Close on Nov 18, 2026Market cap $46.89KP/E –Yield –

Profusa net income

Net income is the profit left for shareholders after every expense, interest and tax.

Profusa's net income for the twelve months ending Jun 30, 2026 was -$42.97M. For fiscal 2025 it was -$35.82M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$35.82M–
FY2024Dec 31, 2024-$9.23M-894.4%
FY2023Dec 31, 2023$1.16M-83.8%
FY2022Dec 31, 2022$7.17M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$8.76M–
Q1 FY2026Mar 31, 2026-$3.46M–
Q4 FY2025Dec 31, 2025-$8.57M–
Q3 FY2025Sep 30, 2025-$22.19M–
Q2 FY2025Jun 30, 2025-$2.35M–
Q1 FY2025Mar 31, 2025-$2.72M–
Q4 FY2024Dec 31, 2024-$2.25M-1054.4%
Q3 FY2024Sep 30, 2024-$2.50M–
Q2 FY2024Jun 30, 2024-$2.41M-382.7%
Q1 FY2024Mar 31, 2024-$2.07M-569.7%
Q4 FY2023Dec 31, 2023$235.97K-51.1%
Q3 FY2023Sep 30, 2023-$367.35K-120.8%
Q2 FY2023Jun 30, 2023$852.39K-29.7%
Q1 FY2023Mar 31, 2023$440.90K-88.1%
Q4 FY2022Dec 31, 2022$482.55K–
Q3 FY2022Sep 30, 2022$1.76M–
Q2 FY2022Jun 30, 2022$1.21M–
Q1 FY2022Mar 31, 2022$3.71M–

More Profusa figures

See a number that looks wrong?